News from Thoratec Corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

07 Oct, 2015, 16:15 ET Thoratec Shareholders Approve St. Jude Medical's Acquisition Of Thoratec

Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts,...


06 Oct, 2015, 08:35 ET Présentation par Thoratec des événements cliniques lors de la conférence de l'Association européenne de chirurgie cardio-thoracique

Thoratec Corporation (NASDAQ : THOR), un leader mondial dans les traitements d'assistance circulatoire mécanique pour sauver,...


06 Oct, 2015, 08:35 ET Thoratec Hebt Die Klinischen Ereignisse Der Jahrestagung Der European Association For Cardio-Thoracic Surgery Hervor

Thoratec Corporation (NASDAQ: THOR), ein weltweit führendes Unternehmen für mechanische Kreislaufsunterstützungstherapien zur...


06 Oct, 2015, 08:21 ET Thoratec Highlights Clinical Events From The European Association For Cardio-Thoracic Surgery Conference

 Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts,...


27 Sep, 2015, 16:00 ET L'évaluation du marquage CE du HeartMate 3™ passe le critère principal d'évaluation

Les points forts comprennent le meilleur taux de survie enregistré lors d'un essai clinique de marquage CE portant sur un appareil...


27 Sep, 2015, 16:00 ET HeartMate 3™ CE-zulassungsstudie erreicht primären endpunkt

Zu den Höhepunkten zählen die beste 6-Monate-Überlebensrate in einer klinischen LVAD/CE-Zulassungsstudie und die niedrige Inzidenz...


14 Sep, 2015, 08:45 ET Thoratec Issues Voluntary Device Correction

Thoratec Corporation (NASDAQ: THOR) today issued a voluntary Urgent Medical Device Correction Letter to all hospitals who have patients supported...


04 Sep, 2015, 08:30 ET Thoratec Announces Start Of Shield II™ U.S. Clinical Trial

 Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts,...


01 May, 2015, 09:00 ET Thoratec Announces Addition To Senior Management Team

 Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts,...


10 Feb, 2015, 16:02 ET Thoratec® Reports Fourth Quarter 2014 Results

Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing...


30 Jan, 2015, 08:45 ET Thoratec Presentation At Leerink Global Healthcare Conference To Be Webcast

 Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore...


28 Jan, 2015, 17:26 ET Thoratec Schedules Fourth Quarter Conference Call, Webcast

Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing...


02 Jan, 2015, 16:09 ET Thoratec Presentation At J.P. Morgan Healthcare Conference To Be Webcast

 Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore...


01 Dec, 2014, 09:00 ET Thoratec Announces Completion Of Enrollment In The HeartMate III™ CE Mark Trial

 Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore...


01 Dec, 2014, 09:00 ET Thoratec gibt die Beendigung des Patienteneinschlusses für die HeartMate III™ CE-Zulassungsstudie bekannt

Thoratec Corporation (NASDAQ: THOR), ein weltweit führendes Unternehmen von mechanischen Kreislaufunterstützungstherapien zur Rettung,...


26 Nov, 2014, 09:00 ET Thoratec Announces Presentations At Investor Conferences For December 2014

 Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore...


06 Nov, 2014, 09:15 ET Thoratec Announces Presentations At Investor Conferences For November 2014

Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing...


05 Nov, 2014, 16:02 ET Thoratec® Reports Third Quarter 2014 Results

 Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore...


15 Oct, 2014, 09:00 ET Thoratec Schedules Third Quarter Conference Call, Webcast

Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing...


06 Oct, 2014, 16:30 ET Thoratec Announces Additions To Senior Management Team

 Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore...


22 Sep, 2014, 07:30 ET Thoratec Appoints D. Keith Grossman President And Chief Executive Officer

Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing...


09 Sep, 2014, 16:45 ET Thoratec Announces Start Of Heartmate III™ U.S. Clinical Trial

Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing...


29 Aug, 2014, 14:47 ET Thoratec Presentation At Morgan Stanley Healthcare Conference To Be Webcast

Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing...


06 Aug, 2014, 16:02 ET Thoratec Announces Start Of The HeartMate PHP™ CE Mark Trial

Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts,...


06 Aug, 2014, 16:02 ET Thoratec Announces $30 Million Accelerated Share Repurchase

Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing...